Seguir
Akshay Desai
Akshay Desai
Assistant Professor of Medicine, Harvard Medical School
Dirección de correo verificada de partners.org
Título
Citado por
Citado por
Año
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
57644*2014
Angiotensin–neprilysin inhibition versus enalapril in heart failure
JJV McMurray, M Packer, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ...
New England Journal of Medicine 371 (11), 993-1004, 2014
75502014
Dapagliflozin in patients with heart failure and reduced ejection fraction
JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ...
New England Journal of Medicine 381 (21), 1995-2008, 2019
65522019
Spironolactone for heart failure with preserved ejection fraction
B Pitt, MA Pfeffer, SF Assmann, R Boineau, IS Anand, B Claggett, ...
New England Journal of Medicine 370 (15), 1383-1392, 2014
28152014
Strategies for multivessel revascularization in patients with diabetes
ME Farkouh, M Domanski, LA Sleeper, FS Siami, G Dangas, M Mack, ...
New England journal of medicine 367 (25), 2375-2384, 2012
22252012
Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction
SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ...
New England Journal of Medicine 381 (17), 1609-1620, 2019
20482019
Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction
SD Solomon, JJV McMurray, B Claggett, RA de Boer, D DeMets, ...
New England Journal of Medicine 387 (12), 1089-1098, 2022
17622022
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ...
New England Journal of Medicine 367 (23), 2204-2213, 2012
16812012
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial
MA Pfeffer, B Claggett, SF Assmann, R Boineau, IS Anand, N Clausell, ...
Circulation 131 (1), 34-42, 2015
10162015
Rehospitalization for heart failure: predict or prevent?
AS Desai, LW Stevenson
Circulation 126 (4), 501-506, 2012
8292012
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure
M Packer, JJV McMurray, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ...
Circulation 131 (1), 54-61, 2015
8172015
2017 cardiovascular and stroke endpoint definitions for clinical trials
KA Hicks, KW Mahaffey, R Mehran, SE Nissen, SD Wiviott, B Dunn, ...
Circulation 137 (9), 961-972, 2018
7022018
Effect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus
ET Kato, MG Silverman, O Mosenzon, TA Zelniker, A Cahn, RHM Furtado, ...
Circulation 139 (22), 2528-2536, 2019
6542019
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
M Vaduganathan, KF Docherty, BL Claggett, PS Jhund, RA de Boer, ...
The Lancet 400 (10354), 757-767, 2022
6432022
Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not …
SM Dunlay, MM Givertz, D Aguilar, LA Allen, M Chan, AS Desai, A Deswal, ...
Circulation 140 (7), e294-e324, 2019
6392019
Treatment of anemia with darbepoetin alfa in systolic heart failure
K Swedberg, JB Young, IS Anand, S Cheng, AS Desai, R Diaz, ...
New England Journal of Medicine 368 (13), 1210-1219, 2013
6102013
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
SD Solomon, B Claggett, EF Lewis, A Desai, I Anand, NK Sweitzer, ...
European heart journal 37 (5), 455-462, 2016
5892016
Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials
AS Desai, JC Fang, WH Maisel, KL Baughman
Jama 292 (23), 2874-2879, 2004
5532004
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin‐converting enzyme inhibition in patients with chronic systolic heart failure: rationale for …
JJV McMurray, M Packer, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ...
European journal of heart failure 15 (9), 1062-1073, 2013
5482013
PARAGON-HF Investigators and Committees. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction
SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ...
N Engl J Med 381 (17), 1609-1620, 2019
5312019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20